13D/13G Filings - CATALYST BIOSCIENCES INC.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-06-19
10:20 am
Sale
2020-06-1813GCatalyst Biosciences, Inc.
CBIO
Assenagon Asset Management S.A.59,771
1.070%
-222,819decrease
(-78.85%)
Filing
History
2020-06-19
10:18 am
Purchase
2020-06-1713GCatalyst Biosciences, Inc.
CBIO
Assenagon Asset Management S.A.282,589
6.390%
282,589increase
(New Position)
Filing
History
2020-03-12
4:58 pm
Purchase
2020-03-0313GCatalyst Biosciences, Inc.
CBIO
Stonepine Capital Management, LLC263,481
6.000%
263,481increase
(New Position)
Filing
History